All Articles

Remission and low disease activity in systemic lupus erythematosus

Impact of probucol on xanthoma reduction and its role in cardiovascular event prevention in familial hypercholesterolemia patients

Risk factors for coronary artery disease in familial hypercholesterolemia

How did we move from the initial concept 24 years ago to the current understanding of treating patients with Fabry Disease? A narrative review and personal perspective

From hype to hope: foundational requirements for NF1 gene therapy success

Discriminating dyslipidemias - a South African perspective

Management strategies using biologics in systemic lupus erythematosus

The clinical landscape of cutaneous neurofibromas in neurofibromatosis type 1

Challenges in pediatric familial hypercholesterolemia management: insights from a survey in Shizuoka, Japan

What influences changes in gait spatiotemporal parameters in boys with Duchenne Muscular Dystrophy? Focusing on contractures, muscle strength, and gait deviations

Systemic lupus erythematosus: management strategies

Inherently inapt: the role of innate immunity in systemic lupus erythematosus pathogenesis

Managing pregnancy in women with sickle cell disease: a focus on physiopathology, risks, and multidisciplinary care

Growth hormone and Prader-Willi syndrome: experience and perspective

A contemporary treatment regimen normalizes muscle mass and adult height in children with Prader-Willi syndrome - a longitudinal analysis

Early diagnosis of systemic lupus erythematosus

Exercise and myasthenia gravis

Potential barriers to reverse cascade screening combined with universal cholesterol screening for paediatric familial hypercholesterolemia: focus on second-degree relatives of a proband